pylori (HP) can inhibit levodopa (LD) in Parkinson's disease (PD) patients leading to motor fluctuation. Objectives: To identify the incidence of HP in PD patients compared to healthy controls ... effect on motor…
Objective: Assessment of dynamic pattern of Motor Fluctuations (MFs) in the patients with Parkinson’s Disease (PD) after complex therapy using intrathecal (endolumbar) route of injecting of cryopreserved stem cells…
mean duration of 8.46 years. Among them, 139 (51.87%) additionally suffered from motor fluctuations and/or dyskinesia. The evaluation was conducted using the 39-item Parkinson’s Disease Questionnaire ... patient…
improving the quality of life of individuals with advanced PD, characterized by Levodopa-induced motor fluctuations and dyskinesia. In addition, there is an impetus for earlier implantation and treatment with
uneven. Moreover, they become less effective after long-term usage and may cause motor fluctuations, abnormal actions, illusion, schizophrenia and other serious side effects. The Eaulier rehabilitation therapies we have…
dopamine replacement therapy; The limitation of dopaminergic therapy is that patients soon develop motor fluctuations, shortening and loss of stability and predictability of the response as well as drug-induced
standard treatment for Parkinson disease (PD). However, its long-term therapy is associated with motor fluctuations and levodopa induced dyskinesia (LID). One of prime causes of these motor complications
typically offered to patients that have diminishing benefits from dopamine replacement therapy with prominent motor fluctuations. Recent research has also shown that DBS can have a significant impact
drugs over time which it implies some serious side effects such as psychosis, motor fluctuations, and dyskinesias. Additionally, PD patients under this type of treatment develop a series of dopa
Treatment of advanced Parkinson’s disease (PD) remains challenging, with fluctuations in motor status often resulting in patients becoming severely handicapped1. The short-acting dopamine D1/D2 receptor agonist…
DOPA-induced motor fluctuations remain as leading causes of disability in ParkinsonâÂ?Â?s disease (PD). Thence, designing strategies to treat L-DOPA-induced motor disorders is a high priority
disease progresses, up to 80% of patients experience ‘wearing-off’ symptoms, dyskinesia and other motor complications. Younger age of Parkinson’s disease onset, disease severity, and high levodopa doses increase…
disease progresses, up to 80% of patients experience ‘wearing-off’ symptoms, dyskinesia and other motor complications. Younger age of Parkinson’s disease onset, disease severity, and high levodopa doses increase…
dopaminergic treatments, while causing additional motor complications or side effects (including wearing off, motor fluctuations, dyskinesias; see Almeida & Hyson, 2010 review). Mobility deficits are arguably the most…
dopaminergic treatments, while causing additional motor complications or side effects (including wearing off, motor fluctuations, dyskinesias; see Almeida & Hyson, 2010 review). Mobility deficits are arguably the most…
first years of the disease in particular. As the degenerative process in PD progresses, motor fluctuations as well as levodopa-associated complications should occur as a result of changes ... approved and under research…
treatment and remains the mainstay one, however long-term use is associated with motor fluctuations and dyskinesias. Propolis is one of the most important resinous natural product with wide range ... Catalepsy…
disorder (with a prevalence of more than 40%) that impacts on QOL, especially in motor fluctuations, ADL, working memory and inhibition tasks, followed by apathy that usually occurs in advanced
continuous infusion, is so far the best in the treatment of PD with severe motor fluctuations not optimally controlled by oral medication. Numerous shortterm and long-term, open-label, uncontrolled
therapy of the disease. Therefore, the risk of onset of motor complications such as motor fluctuations and dyskinesia might be alleviated1. This study has been aimed to synthesize novel heterobivalent
high dosage of the drug. Moreover, it also causes motor complications such as motor fluctuations and dyskinesia. In this multidisciplinary project, we have aimed for developing hetero-bivalent ligands that
high dosage of the drug. Moreover, it also causes motor complications such as motor fluctuations and dyskinesia. In this multidisciplinary project, we have aimed for developing hetero-bivalent ligands that
advanced PD patients who have completely utilized standard treatments and still suffer from persistent motor fluctuations. Emerging therapies and surgical procedures will provide enhanced symptomatic control remain in…
open-labeled, prospective study that enrolled 15 PD patients (Men 8, Women 7) with motor fluctuations who fully filled UK PD society brain bank clinical diagnostic criteria. We added
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.